Personalized Medicine

Personalized medicine helps determine an individual’s predisposition to a particular disease or condition, and allows physicians to prescribe individualized and efficient treatments based on each patient’s genetic profiles, increasing the effectiveness of treatment while reducing the risk of adverse side effects.

MOUNT SINAI SERVICES is a leading centre for the development and delivery of pharmacogenomic assays and companion diagnostics in this emerging field.

Development and Validation Services

MSS has specialized expertise in the discovery, development and validation of prognostic, diagnostic and theranostic biomarker assays.

Experience with FDA and Health Canada regulatory requirements for LDTs and IVDs
Conventional and multiplex immunoassays (chip- and bead-based)
Histopathological markers (FISH, IHC)
Genetic markers (PCR, microarrays, conventional and next-gen sequencing)
Point of Care applications

Molecular Diagnostic Testing Services

MSS is an experienced partner in the commercialization and launch of molecular and companion diagnostic assays. We offer a range of advanced molecular tests through our GLP certified, CLIA-compliant clinical diagnostic laboratories:

First in Canada to offer the KRAS companion diagnostic assay for patients with colorectal cancer.
First in Canada to offer aCGH Preimplantation Genetic Screening to support in vitro fertilization.
MSS provides access to one of only two reference centres for HER2/neu testing in Ontario, which helps determine the best course of therapy for patients with breast cancer.

MSS’ offering of pharmacogenomic and companion diagnostic assays will continue to expand across a wide range of therapeutic areas. MSS will also soon offer physicians the ability to order certain personalized tests on-line.